Wilton, CT, United States of America

Novo Laboratories, Incorporated


USPTO Granted Patents = 8

Forward Citations = 101

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Michael K Weibel (3 out of 20 patents)

silverMedal Joseph Spina (2 out of 3 patents)

bronzeMedal Raymond P Lanzilotta (2 out of 2 patents)

4.  Columbus O Boyce (2 out of 3 patents)

5.  Theodore M Wong (2 out of 2 patents)

6.  John O Carroll (1 out of 2 patents)

7.  William H McMullen (1 out of 2 patents)

8.  Leonard L Ciaccio (1 out of 2 patents)

9.  William Carasik (1 out of 2 patents)

10.  Dennis M Katkocin (1 out of 4 patents)

11.  Robert L Starnes (1 out of 1 patent)

12.  Carl A Miller (1 out of 1 patent)

13.  Robert J Strobel, Jr (1 out of 1 patent)

14.  Charles A Starace (1 out of 1 patent)


8 patents:

Company Overview
Novo Laboratories, Inc. is a leading pharmaceutical company focused on developing innovative and life-changing medications. With a dedication to research and development, Novo Labs is committed to improving the health and well-being of patients worldwide. Our team of experts work tirelessly to bring innovative solutions to complex healthcare challenges, with a focus on providing high-quality, safe, and effective medicines to those in need.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#12 in Wilton, CT

#750 in Connecticut

#35,941 in US

Wilton, CT (US)
Wilton, CT, United States of America
Forward Citations = 101

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novo Laboratories, Incorporated. Retrieved from https://idiyas.com/company/novo-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…